The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP)

BACKGROUND: The Glivec International Patient Assistance Program (GIPAP) is a unique direct-to-patient program that provides imatinib (Glivec) at no cost to eligible patients in low- and middle-income countries (LMICs) with chronic myelogenous leukemia (CML) or gastrointestinal stromal tumor (GIST)....

Full description

Saved in:
Bibliographic Details
Published in:EClinicalMedicine
Main Authors: Umeh, Chukwuemeka A., Garcia-Gonzalez, Pat, Tremblay, David, Laing, Richard
Format: Artigo
Language:Inglês
Published: Elsevier 2020
Subjects:
Research paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046500/
https://ncbi.nlm.nih.gov/pubmed/32140674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100257
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items